Vimarsana
Biggest News Aggregation in the World

Page 43 - Lead Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lead Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lead Author Today - Breaking & Trending Today

"We want to hook people on hope, not on fear" - Vimarsana News

"We want to hook people on hope, not on fear"

Interview with Nanette Braun, Chief, Communications Campaigns, United Nations, by Dr Alexandra Borchardt, Lead Author, EBU News Report 2023: Climate Journalism That Works - Between Knowledge and Impact Nanette Braun leads communications campaigns at the United Nations. She has risen through different...

Source: ebu.ch
Avoiding unhealthy dietary habits could help prevent aggressive prostate cancer - Vimarsana News

Avoiding unhealthy dietary habits could help prevent aggressive prostate cancer

A study published in BJU International found that adhering to healthy diets seems to have no effect on prostate cancer risk, but following an unhealthy diet might increase the risk of developing aggressive prostate cancer.

Talking therapies for depression may be linked to reduced rates of future cardiovascular disease - Vimarsana News

Talking therapies for depression may be linked to reduced rates of future cardiovascular disease

Using talking therapies to effectively treat depression in adults over the age of 45 may be linked with reduced rates of future cardiovascular disease, finds a new analysis of health data led by UCL researchers.

Researchers reveal how a new CALM mutation causes deadly arrhythmias - Vimarsana News

Researchers reveal how a new CALM mutation causes deadly arrhythmias

Arrhythmia, when left unchecked, can be life-threatening.

Bicycle Therapeutics plc: Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting - Vimarsana News

Bicycle Therapeutics plc: Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced